Anika Schick
Anika Schick has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Charles S. Elmore
Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, Boston, USA
2 shared publications Anna Holub
Sanofi-Aventis Deutschland GmbH, R&D, Integrated Drug Discovery, Industriepark Höchst, Frankfurt am Main, Germany
1 shared publication- Christoph Alexander Bauer
Data Science and Modelling, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden
1 shared publication Hans Christian D. Hammershøj
Interdisciplinary Nanoscience Center (iNANO) and Department of Chemistry, Aarhus University, Aarhus, Denmark
1 shared publication- Johan Broddefalk
Medicinal Chemistry CVRM, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43183 Mölndal, Sweden
1 shared publication - Kim S. Mühlfenzl
Interdisciplinary Nanoscience Center (iNANO) Department of Chemistry Aarhus University Gustav Wieds Vej 14 8000 Aarhus C Denmark
1 shared publication
Latest Publications
- Open Access
- 12 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 5307
Late-stage generation of 14C/3H-radiolabeled lysine residues via hydroformylation of peptides
Peptides constitute a well-established and rapidly expanding field in the contemporary pharmaceutical drug landscape. Studies with 14 C- or 3 H-radiolabeled analogs are the gold standard for drug development, yet access to 14 C-peptides is costly and limited to derivatization of the native structure with tags or lengthy multi-step syntheses. In this work, we report a platform that installs 14 C- or 3 H-radiolabeled lysine residues directly on solid-supported peptides. The workflow constitutes a mild, peptide-compatible hydroformylation process of allylglycine residues to generate labeled allysine, followed by reductive amination that furnishes radiolabeled lysine residues directly upon cleavage from the solid support. The hydroformylation setup can be tuned for flexible isotope introduction by using 14 CO from solid precursors and 3 H 2 from standard tritium manifolds. We show that the optimized workflow tolerates diverse sequences and enables functionalization of peptides as complex as semaglutide analogs.
- 12 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 5307
Open AccessLate-stage generation of 14C/3H-radiolabeled lysine residues via hydroformylation of peptides
Peptides constitute a well-established and rapidly expanding field in the contemporary pharmaceutical drug landscape. Studies with 14 C- or 3 H-radiolabeled analogs are the gold standard for drug development, yet access to 14 C-peptides is costly and limited to derivatization of the native structure with tags or lengthy multi-step syntheses. In this work, we report a platform that installs 14 C- or 3 H-radiolabeled lysine residues directly on solid-supported peptides. The workflow constitutes a mild, peptide-compatible hydroformylation process of allylglycine residues to generate labeled allysine, followed by reductive amination that furnishes radiolabeled lysine residues directly upon cleavage from the solid support. The hydroformylation setup can be tuned for flexible isotope introduction by using 14 CO from solid precursors and 3 H 2 from standard tritium manifolds. We show that the optimized workflow tolerates diverse sequences and enables functionalization of peptides as complex as semaglutide analogs.
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 13 (15) , 4670-4680
High-throughput hydrogen isotope exchange via transfer deuteration
We developed a rapid screening protocol based on transfer deuteration using formic acid- d 2 as the deuterium source. These conditions allow rapid screening of up to 96 hydrogen-isotope-exchange reactions in a controlled and safe manner.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 13 (15) , 4670-4680
Open AccessHigh-throughput hydrogen isotope exchange via transfer deuteration
We developed a rapid screening protocol based on transfer deuteration using formic acid- d 2 as the deuterium source. These conditions allow rapid screening of up to 96 hydrogen-isotope-exchange reactions in a controlled and safe manner.